AU5978596A - Liposomes containing human immunodeficiency virus glycoprote in and methods for use thereof - Google Patents

Liposomes containing human immunodeficiency virus glycoprote in and methods for use thereof

Info

Publication number
AU5978596A
AU5978596A AU59785/96A AU5978596A AU5978596A AU 5978596 A AU5978596 A AU 5978596A AU 59785/96 A AU59785/96 A AU 59785/96A AU 5978596 A AU5978596 A AU 5978596A AU 5978596 A AU5978596 A AU 5978596A
Authority
AU
Australia
Prior art keywords
glycoprote
methods
immunodeficiency virus
human immunodeficiency
containing human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU59785/96A
Other languages
English (en)
Inventor
Carl L. Alving
Nabila Wassef
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Army
Original Assignee
US Department of Army
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Army filed Critical US Department of Army
Publication of AU5978596A publication Critical patent/AU5978596A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU59785/96A 1995-06-07 1996-06-07 Liposomes containing human immunodeficiency virus glycoprote in and methods for use thereof Abandoned AU5978596A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US472780 1990-01-31
US47278095A 1995-06-07 1995-06-07
PCT/US1996/008680 WO1996040243A1 (fr) 1995-06-07 1996-06-07 Liposomes contenant une glycoproteide du virus de l'immunodeficience humaine et leurs procedes d'utilisation

Publications (1)

Publication Number Publication Date
AU5978596A true AU5978596A (en) 1996-12-30

Family

ID=23876919

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59785/96A Abandoned AU5978596A (en) 1995-06-07 1996-06-07 Liposomes containing human immunodeficiency virus glycoprote in and methods for use thereof

Country Status (2)

Country Link
AU (1) AU5978596A (fr)
WO (1) WO1996040243A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200726479A (en) 2005-04-12 2007-07-16 Univ Duke Method of inducing neutralizing antibodies to human immunodeficiency virus
EP2139516A4 (fr) * 2007-04-13 2011-06-29 Univ Duke Methode visant a induire des anticorps neutralisants contre le virus de l'immunodeficience humaine
US10076567B2 (en) 2013-09-27 2018-09-18 Duke University MPER-liposome conjugates and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2086094C (fr) * 1990-06-29 2000-05-30 Gail L. Barchfeld Compositions de vaccin renfermant des liposomes
WO1993019775A1 (fr) * 1992-03-31 1993-10-14 Medimmune, Inc. Administration de liposomes contenant des peptides ou des proteines comportant des determinants antigeniques de ctl de proteines vih
WO1993022343A1 (fr) * 1992-05-01 1993-11-11 The Rockfeller University Systeme antigenique a plusieurs peptides possedant des proprietes d'adjuvant, vaccins prepares a partir dudit systeme

Also Published As

Publication number Publication date
WO1996040243A1 (fr) 1996-12-19

Similar Documents

Publication Publication Date Title
AU703128B2 (en) Device in inhalers
IL118237A0 (en) Polysiloxane-polyol macromers their preparation and their use
ZA964334B (en) Metallocene preparation and use
IL116851A0 (en) 3-arylidene-2-oxindole derivatives their preparation and use
PL322624A1 (en) Skin care composition containing retinoides and liposomes
IL122215A0 (en) Dolastatin derivatives their preparation and use
IL118442A0 (en) Triazolymethyl-cyclopentanols their preparation and use
ZA967654B (en) Electrodes and methods of preparation thereof
AU7721796A (en) Skin care preparation and method
AU1372897A (en) 2-amino-heterocycles and therapeutic uses therefor
AU7319994A (en) Nucleotide preparation and uses thereof in wound healing
IL118441A0 (en) Triazolymethyl-oxiranes their preparation and use
GB2304309B (en) Laminate and use thereof
AU7216996A (en) A paf-acetylhydrolase and use in therapy
IL118443A0 (en) Cycloalkane-benzylidene derivatives their preparation and use
IL116710A0 (en) Substituted 2-phenylpyridines their preparation and use
AUPN631395A0 (en) Vaccine and biological vector(II)
ZA96240B (en) Novel peptides their preparation and use
AU7015396A (en) Cyclin e variants and use thereof
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
IL123092A0 (en) Pyrazol-4-ylbenzoyl derivatives their preparation and use
AU5978596A (en) Liposomes containing human immunodeficiency virus glycoprote in and methods for use thereof
IL116658A0 (en) Peptides their preparation and use
AU6975996A (en) Stabilized agchemical concentrate and use thereof
AU4767896A (en) Human immunodeficiency virus transcription inhibitors and methods of their use